Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for teen depression? drug trial targets symptoms in japanese youth

NCT ID NCT07204314

Recruiting now Symptom relief Sponsor: Takeda Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times

Summary

This study tests whether a daily medication called vortioxetine can safely reduce depression symptoms in Japanese teenagers aged 12 to 17 with major depressive disorder. About 180 participants will receive either the drug or a placebo for 14 weeks, with follow-up for 4 more weeks. The goal is to see if the drug improves mood and daily function better than a sugar pill.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MAJOR DEPRESSIVE DISORDER

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Aiiku Clinic

    RECRUITING

    Minato-ku, Tokyo, Japan

  • Bandai Mental Clinic

    RECRUITING

    Chuo-ku, Niigata, Japan

  • Cerisier Heart Clinic

    RECRUITING

    Kagoshima, Japan

  • Chikama Clinic

    RECRUITING

    Miyazaki, Japan

  • Dokkyo Medical University Saitama Medical Center

    RECRUITING

    Koshigaya, Saitama, Japan

  • Harai Clinic

    RECRUITING

    Chuo-ku, Tokyo, Japan

  • Hirosaki University Hospital

    RECRUITING

    Hirosaki, Aomori, Japan

  • Hokkaido University Hospital

    RECRUITING

    Sapporo, Hokkaido, Japan

  • Imurokokorono-clinic

    RECRUITING

    Urasoe, Okinawa, Japan

  • Jisenkai Nanko Psychiatric Institute

    RECRUITING

    Shirakawa, Fukushima, Japan

  • Kai Kokoro Clinic

    RECRUITING

    Suginome, Tokyo, Japan

  • Kaku Mental Clinic

    RECRUITING

    Chūōku, Fukuoka, Japan

  • Kanagawa Children's Medical Center

    RECRUITING

    Yokohama, Kanagawa, Japan

  • Kindai University Hospital

    RECRUITING

    Ōsaka-sayama, Osaka, Japan

  • Kochi Medical School Hospital

    RECRUITING

    Nankoku, Kochi, Japan

  • Miyakonojo Shinsei Hospital

    RECRUITING

    Miyakonojō, Miyazaki, Japan

  • NHO Shikoku Medical Center for Children and Adults

    RECRUITING

    Zentsujichó, Kagawa-ken, Japan

  • Nagoya City University Hospital

    RECRUITING

    Nagoya, Aichi-ken, Japan

  • Nara Medical University Hospital

    RECRUITING

    Kashihara, Nara, Japan

  • National Center of Neurology and Psychiatry

    RECRUITING

    Kodaira, Tokyo, Japan

  • Osaka Metropolitan University Hospital

    RECRUITING

    Osaka, Japan

  • Pauroom

    RECRUITING

    Minato-ku, Tokyo, Japan

  • Shin-Otsuka Clinic

    RECRUITING

    Toshima-ku, Tokyo, Japan

  • St. Marianna University School of Medicine Hospital

    RECRUITING

    Kawasaki, Kanagawa, Japan

  • Tohoku University Hospital

    NOT_YET_RECRUITING

    Sendai, Miyagi, Japan

  • Tokyo Metropolitan Children's Medical Center

    RECRUITING

    Fuchū, Tokyo, Japan

  • Toyama University Hospital

    RECRUITING

    Toyama, Japan

  • University of the Ryukyus Hospital

    RECRUITING

    Ginowan, Okinawa, Japan

  • Yokohama City University Hospital

    RECRUITING

    Yokohama, Kanagawa, Japan

  • Yuge Neuropsychiatric Hospital

    RECRUITING

    Kumamoto, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.